Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
dinoproston 10 mg/ml koncentrat til infusionsvæske, ampul a 0,5 ml med diluent |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
ergometrinmaleat 500 µg/1 ml injektionsvæske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
ergometrinmaleat + oxytocin 500 µg/5 enheder/ml injektionsvæske, opløsning, ampul a 1 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
oxytocin 5 enheder/ml injektionsvæske, opløsning, ampul a 1 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
oxytocin 10 enheder/ml injektionsvæske, opløsning, ampul a 1 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
alprostadil 500 µg/ml koncentrat til infusionsvæske, ampul a 1 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
carboprost 250 µg/ml injektionsvæske, opløsning, ampul a 1 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
ritodrinhydrochlorid 10 mg/ml injektionsvæske, opløsning, ampul a 5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
atosiban 7,5 mg/ml injektionsvæske, opløsning, hætteglas a 0,9 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
atosiban 7,5 mg/ml koncentrat til infusionsvæske, hætteglas a 5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
medroxyprogesteronacetat 150 mg/ml injektionsvæske, suspension i fyldt injektionssprøjte a 1 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
norethisteronenanthat 200 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
carbachol 250 µg/ml injektionsvæske, opløsning, ampul a 1 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
kollagen 35 mg/ml implantat 2,5 ml i fyldt injektionssprøjte |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
alprostadil 5 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
alprostadil 10 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
alprostadil 20 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
alprostadil 10 µg cylinderampul med injektionsvæske, startpakning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
alprostadil 20 µg cylinderampul med injektionsvæske, startpakning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
alprostadil 10 µg pulver og solvens til injektionsvæske, opløsning, cylinderampul |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
alprostadil 20 µg pulver og solvens til injektionsvæske, opløsning, cylinderampul |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
alprostadil 40 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
alprostadil 40 µg cylinderampul med injektionsvæske, startpakning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
alprostadil 40 µg pulver og solvens til injektionsvæske, opløsning, cylinderampul |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
alprostadil 20 µg cylinderampul med injektionsvæske i sprøjte |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
alprostadil 10 µg cylinderampul med injektionsvæske i sprøjte |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
papaverin injektionsvæske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
papaverin 40 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
carmustin 100 mg pulver og solvens til injektionsvæske, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
cyclophosphamid 200 mg pulver til infusionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
cyclophosphamid 500 mg pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
cyclophosphamid 1 g pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Ifosfamide 1 g powder for solution for injection vial |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Ifosfamide 2 g powder for solution for injection vial |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
melphalan 50 mg pulver og solvens til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
mechlorethaminhydrochlorid 10 mg injektionsvæske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Product containing precisely thiotepa 15 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
treosulfan 5 g pulver til injektionsvæske, rekonstitution, + solvens + sæt |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Treosulfan 1 g powder for solution for injection vial |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Product containing precisely dactinomycin 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Product containing precisely bleomycin (as bleomycin sulfate) 15 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Doxorubicin hydrochloride 10 mg powder for solution for injection vial |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Product containing precisely doxorubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
liposomalt doxorubicinhydrochlorid 2 mg/ml koncentrat til infusionsvæske, hætteglas a 10 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
epirubicinhydrochlorid 2 mg/ml infusionsvæske, opløsning, hætteglas a 5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
epirubicinhydrochlorid 50 mg/25 ml injektionsvæske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Epirubicin hydrochloride 10 mg powder for solution for injection vial |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Epirubicin hydrochloride 20 mg powder for solution for injection vial |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Product containing precisely epirubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Product containing precisely mitomycin 40 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Mitomycin 20 mg powder for solution for injection vial |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Product containing precisely mitomycin 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Mitomycin 2 mg powder for solution for injection vial |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Product containing precisely idarubicin hydrochloride 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Product containing precisely idarubicin hydrochloride 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Product containing precisely aclarubicin 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
liposomalt daunorubicin 2 mg/ml injektionsvæske, emulsion, hætteglas a 25 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Product containing precisely daunorubicin (as daunorubicin hydrochloride) 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
cytarabin 100 mg/ml injektionsvæske, opløsning, hætteglas a 5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
cytarabin 100 mg/ml injektionsvæske, opløsning, hætteglas a 20 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
cytarabin 20 mg/ml injektionsvæske, opløsning, hætteglas a 25 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
cytarabin 1 g pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
cytarabin 20 mg/ml injektionsvæske, opløsning 5ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
cytarabin 100 mg/ml injektionsvæske, opløsning, hætteglas a 1 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
cytarabin 100 mg/ml injektionsvæske, opløsning, hætteglas a 10 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
cytarabin 100 mg pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Product containing precisely cytarabine 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
fluoruracil 25 mg/ml, opløsning til injektion, hætteglas a 100 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
fluoruracil 500 mg/10 ml injektionsvæske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
fluorouracil 50 mg/ml injektionsvæske, opløsning, hætteglas a 50 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
fluoruracil 25 mg/ml, opløsning til injektion, hætteglas a 10 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
fluoruracil 25 mg/ml, opløsning til injektion, hætteglas a 20 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
methotrexat 2,5 mg/ml injektionsvæske, opløsning, hætteglas a 2 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
methotrexat 25 mg/ml injektionsvæske, opløsning, hætteglas a 2 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
methotrexat 25 mg/ml injektionsvæske, opløsning, hætteglas a 8 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
methotrexat 25 mg/ml injektionsvæske, opløsning, hætteglas a 20 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
methotrexat 25 mg/ml injektionsvæske, opløsning, hætteglas a 40 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
methotrexat 25 mg/ml injektionsvæske, opløsning, hætteglas a 200 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
methotrexat 100 mg/ml injektionsvæske, opløsning, hætteglas a 10 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
methotrexat 100 mg/ml injektionsvæske, opløsning, hætteglas a 50 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Product containing precisely gemcitabine (as gemcitabine hydrochloride) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Product containing precisely gemcitabine (as gemcitabine hydrochloride) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Raltitrexed 2 mg powder for solution for injection vial |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Etoposide (as etoposide phosphate) 100 mg powder for solution for injection vial |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
etoposid 100 mg/5 ml infusionsvæske, koncentrat |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
vinblastinsulfat 10 mg pulver til injektionsvæske, rekonstitution + solvens |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
vinblastinsulfat 10 mg/10 ml injektionsvæske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
vincristin 1 mg pulver og solvens til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
vincristin 2 mg pulver og solvens til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
vincristin 5 mg pulver og solvens til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
vincristinsulfat 1 mg/1 ml i fyldt injektionssprøjte |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
vincristinsulfat 2 mg/2 ml i fyldt injektionssprøjte |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
vincristinsulfat 5 mg/5 ml injektionsvæske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
vincristinsulfat 1 mg/1 ml injektionsvæske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
vincristinsulfat 2 mg/2 ml injektionsvæske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Product containing precisely vindesine sulfate 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
vinorelbin 10 mg/1 ml infusionsvæske, opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
vinorelbin 50 mg/5 ml infusionsvæske, opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
amsacrin 5 mg/ml koncentrat til infusionsvæske, hætteglas a 15 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
carboplatin 10 mg/ml infusionsvæske, opløsning, hætteglas a 5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
carboplatin 10 mg/ml infusionsvæske, opløsning, hætteglas a 45 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|